K2 (MK-7)
La vitamine K2 (MK-7) est une vitamine liposoluble qui joue un rôle crucial dans la santé des os et le système cardiovasculaire. Il s'agit d'un sous-type de vitamine K2, connu sous le nom de ménaquinone-7, qui est produit par fermentation bactérienne.
Aperçu de l'Efficacité et des Risques
Condition | Efficacité | Détails |
|---|---|---|
| Ostéoporose | MK-7 supplementation has been associated with improved bone mineral density and reduced risk of osteoporotic fractures, particularly in older adults and postmenopausal women, by enhancing bone mineralization. | |
| Santé cardiovasculaire | By preventing arterial calcification and supporting vascular health, K2 (MK-7) contributes to overall cardiovascular health. Research indicates a reduction in cardiovascular events and mortality with adequate MK-7 intake. | |
| Santé des os | MK-7, a form of Vitamin K2, is crucial for bone health as it helps in the activation of osteocalcin, a protein necessary for bone mineralization. Studies have demonstrated that MK-7 supplementation can improve bone density and reduce the risk of fractures. | |
| Calcification artérielle/Athérosclérose | K2 (MK-7) has been shown to inhibit the progression of arterial calcification and reduce the risk of cardiovascular disease by activating matrix Gla protein (MGP), a potent inhibitor of arterial calcification. Clinical trials and observational studies support its beneficial effects on cardiovascular health. | |
| Calcification vasculaire | K2 (MK-7) is known to prevent vascular calcification by activating MGP. This action is critical in reducing the risk of cardiovascular diseases associated with calcification. | |
| Peut interagir avec les anticoagulants. | La vitamine K2 (MK-7) peut contrecarrer les effets des médicaments anticoagulants, tels que la warfarine, en favorisant la coagulation sanguine, ce qui peut entraîner un risque accru de thrombose. |
Complément Recommandé